Cited by 206Antioxidant Activity and Oxidative StressNeurological Disorders and TreatmentsMedicinal Plants and Neuroprotection

A Review for the Pharmacological Effect of Lycopene in Central Nervous System Disorders

Open access
Chen, Dongjian, Huang, Chao, Chen, Zhuo·2019·Biomedicine & Pharmacotherapy

Abstract

Lycopene is an aliphatic hydrocarbon carotenoid extracted from plants like tomatoes, papayas, and watermelons. Previous studies have shown that lycopene can exert prophylactic and/or therapeutic effects in different disorders, such as heart failure and neoplasm via anti-oxidative, anti-inflammatory, and anti-proliferative activities. In the central nervous system (CNS), lycopene also has prophylactic and/or therapeutic effects in different type of disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), cerebral ischemia, epilepsy, and depression. Lycopene also improves cognition and memory ability of rodents in different pathological conditions, such as diabetes, colchicine exposure, high-fat diet (HFD), and aging. Further, lycopene can prevent neuro-toxicities induced by monosodium glutamate (MSG), trimethyltin (TMT), methylmercury (MeHg), tert-butyl hydroperoxide (t-BHP), and cadmium (Cd). In some special conditions such as ethanol addiction and haloperidol-induced orofacial dyskinesia, lycopene administration displays special therapeutic effects. Mechanisms including inhibition of oxidative stress and neuroinflammation, inhibition of neuronal apoptosis, and restoration of mitochondrial function have been shown to mediate the neuroprotective effects of lycopene. Other mechanisms, such as inhibition of nuclear factor-κB (NF-κB) and c-Jun N-terminal kinase (JNK), activation of the nuclear factor erythroid 2-related factor (Nrf2) and brain-derived neurotrophic factor (BDNF) signaling, and restoration of intracellular Ca 2+ homeostasis, may be also involved in the neuroprotective effect of lycopene. In hope of get a clear impression about the role of lycopene in the CNS, we summarize and discuss the pharmacological effects of lycopene as well as its possible mechanisms in CNS disorder prevention and/or therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2018.12.151

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chen, D., Huang, C., & Chen, Z.
Affiliations
  • Second Affiliated Hospital of Nantong University (CN)
  • Nantong University (CN)
Corresponding author
  • Chen, Dongjian
  • Chen, Zhuo
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2019-03
Volume
111
Pages
791-801
ISSN
0753-3322 (ISSN-L)
OpenAlex
W2907267538
Cited by
206
References
144
Citations by year
2026: 18 · 2025: 24 · 2024: 38 · 2023: 30 · 2022: 25 · 2021: 39 · 2020: 28 · 2019: 2
FWCI
2.27
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of China (81571323, 81771467, 81701286)
  • Nantong First People’s Hospital (YJ201601)
Topics
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords
lycopene, carotenoids, neuroprotection, central nervous system disorders, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischemia, epilepsy, depression, neuroinflammation, oxidative stress, neuronal apoptosis, mitochondrial function, Nrf2 signaling, BDNF signaling, calcium homeostasis, neurotoxicity, cognitive impairment, ethanol addiction, orofacial dyskinesia
MeSH terms
Lycopene, Animals, Carotenoids, Central Nervous System Diseases, Humans, Plant Extracts, Treatment Outcome, Oxidative Stress, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review